10-QSMMTCIK 0001599298
Summit Therapeutics Inc.
Quarterly report (10-Q) filed .
Unaudited quarterly financial report filed by U.S. public companies for the first three fiscal quarters.
Filing facts
- Accession number
- 0001599298-26-000039
- Filer
- Summit Therapeutics Inc.
- Ticker
- SMMT
- CIK
- 0001599298
- Form type
- 10-Q
- Form description
- Quarterly report
- Filed at
- April 30, 2026
- Last verified
- May 1, 2026SecFilingDex pulls from EDGAR with daily cadence
Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1599298/000159929826000039/0001599298-26-000039-index.htm ↗Filer's full EDGAR submission history
EDGAR · Summit Therapeutics Inc. (0001599298) ↗Machine-readable JSON twin (LLM-citation friendly)
/api/filing/0001599298-26-000039.jsonSecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.